Westborough, MA, United States of America

Zehra Kaymakcalan

This inventor holds 32 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Biopharmaceutical Compositions. Top assignees: Abbvie Inc., Abbott Biotechnology Ltd., Abbott Gmbh & Co Kg. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zehra Kaymakcalan. Retrieved from https://idiyas.com/inventor/zehra-kaymakcalan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 14)

% Patents Active = 46.9

CIPO Patents = 5 (Patent Applications = 8)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 7.2

ph-index = 20

Forward Citations = 2,489(Granted Patents)

Location History:

Westboro, MA (US) (2000 - 2013)
Westborough, MA (US) (2005 - 2016)

Company Filing History:

Abbott Biotechnology Ltd.

Abbvie Biotechnology Ltd

patents

5. 3 out of 10,816

Basf Aktiengesellschaft

patents

6. 1 out of 4,188

Abbott Laboratories Corporation

patents

7. 1 out of 167

Abbvie Deutschland Gmbh and Co Kg

patents

Years Active: 2000-2016

Loading Chart...

Areas of Expertise:

Human Antibodies

TNFα

IL-12

Binding Proteins

Dual Specificity Antibodies

Modulated Lysine Variants

Low Acidic Species

Anti-TNF Antibodies

Compositions

Methods of Treatment

Rheumatoid Arthritis

P40 Subunit

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9522953 - Low acidic species compositions and methods for producing and using the same (2016-12-20),

2. 9499616 - Modulated lysine variant species compositions and methods for producing and using the same (2016-11-22),

3. 9321846 - Compositions and methods comprising binding proteins for adalimumab (2016-04-26),

4. 9315574 - Low acidic species compositions and methods for producing and using the same (2016-04-19),

5. 9266949 - Low acidic species compositions and methods for producing and using the same (2016-02-23),

6. 9200070 - Low acidic species compositions and methods for producing and using the same (2015-12-01),

7. 9200069 - Low acidic species compositions and methods for producing and using the same (2015-12-01),

8. 9181337 - Modulated lysine variant species compositions and methods for producing and using the same (2015-11-10),

9. 9085618 - Low acidic species compositions and methods for producing and using the same (2015-07-21),

10. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same (2015-05-19),

11. 8969024 - Compositions and methods comprising binding proteins for adalimumab (2015-03-03),

12. 8921526 - Mutated anti-TNFα antibodies and methods of their use (2014-12-30),

13. 8865174 - Methods of treatment using human antibodies that bind IL-12 (2014-10-21),

14. 8846046 - Low dose methods for treating disorders in which TNFα activity is detrimental (2014-09-30),

15. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),

Title: The Innovative Journey of Zehra Kaymakcalan

Introduction: Zehra Kaymakcalan, a pioneering inventor based in Westborough, MA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Zehra Kaymakcalan holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing her expertise in cutting-edge technologies.

Career Highlights: With a background in computer science and engineering, Zehra Kaymakcalan has worked for top tech companies, leading research institutions, and universities, where she has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout her career, Zehra Kaymakcalan has collaborated with renowned experts in the field, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in technology.

Conclusion: Zehra Kaymakcalan's passion for innovation, coupled with her technical acumen, has solidified her reputation as a trailblazer in the world of technology, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.